Behavioral and endocrine changes reflecting PTSD symptoms in animal models have demonstrated prevention by a cannabinoid 1 receptor agonist or genetic enhancement of endocannabinoids (17). This evidence concerns the gene CNR1 and post-traumatic stress disorder.